CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
48.56
+0.15 (0.31%)
At close: May 18, 2026, 4:00 PM EDT
48.28
-0.28 (-0.58%)
Pre-market: May 19, 2026, 5:59 AM EDT
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $4.68 billion as of May 19, 2026. Its market cap has increased by 42.75% in one year.
Market Cap
4.68B
Enterprise Value
3.03B
1-Year Change
42.75%
Ranking
Category
Stock Price
$48.56
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $4.68B, an increase of 736.20%. That is a compound annual growth rate of 24.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 4.68B | -6.28% |
| Dec 31, 2025 | 5.00B | 48.76% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 5.55B |
| Immunovant | 5.40B |
| Cogent Biosciences | 5.36B |
| Xenon Pharmaceuticals | 5.19B |
| Legend Biotech | 5.01B |
| Dianthus Therapeutics | 4.57B |
| Caris Life Sciences | 4.27B |
| Ligand Pharmaceuticals | 4.17B |